NEWARK, Del., Oct. 30, 2025 (GLOBE NEWSWIRE) — Artesian Resources Corporation (Nasdaq: ARTNA), a leading provider on the Delmarva Peninsula of water and wastewater services, and a number of other related business services, today announced third quarter and year-to-date results for 2025.  Diluted net income per share increased to $0.68 in the third quarter and $1.81 year-to-date Net income increased $0.1 million (2.2%) in the third quarter and $2.1 million (12.9%) year-to-date Invested $40.5 million year-to-date in water and wastewater infrastructureThird Quarter Results Net income for the three months ended September 30, 2025 was $7.0 million, a $0.1 million, or 2.2%, increase compared to net income for the three months ended September 30, 2024. Diluted net income per share increased 3.0% to $0.68, compared to $0.66 for the...

HONG KONG, Oct. 30, 2025 (GLOBE NEWSWIRE) — SAMFINE CREATION HOLDINGS GROUP LIMITED (Nasdaq: SFHG) (the “Company” or “Samfine”), a printing service provider headquartered in Hong Kong, today announced its unaudited financial results for the six months ended June 30, 2025. Overview:Revenue was HK$82.1 million (US$10.5 million) for the six months ended June 30, 2025, representing an increase of 0.2% from HK$81.9 million for the same period in 2024. Net loss was HK$8.5 million (US$1.1 million) for the six months ended June 30, 2025, as compared with a net income of HK$0.8 million for the same period in 2024.Six Months Ended June 30, 2025 Financial Results Revenue. Revenue remained relatively stable at HK$82,121,233 (US$10,461,437) for the six months ended June 30, 2025, representing a marginal increase of 0.2% compared to HK$81,934,259...

Company delivers 99th consecutive quarter of topline growthThird quarter 2025 revenue grew 16% and recurring revenue grew 18% from the third quarter of 2024Appoints new Chief Commercial Officer as longtime Chief Revenue Officer intends to retireAnnounces new Share Repurchase Program MINNEAPOLIS, Oct. 30, 2025 (GLOBE NEWSWIRE) — SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail supply chain cloud services, today announced financial results for the third quarter ended September 30, 2025. Financial Highlights Third Quarter 2025 Financial HighlightsRevenue was $189.9 million in the third quarter of 2025, compared to $163.7 million in the third quarter of 2024, reflecting 16% growth. Recurring revenue grew 18% from the third quarter of 2024. Net income was $25.6 million or $0.67 per diluted share, compared to net income of $23.5...

Board approves Quarterly Cash Dividend SANTA MONICA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — JAKKS Pacific, Inc. (NASDAQ: JAKK) today reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025Net sales were $211.2 million, a year-over-year decrease of $110.4 million or 34%, driven largely by a reduction in direct-import sales due to a combination of customers anticipating lower consumer demand in response to tariff-driven price increases and the lack of new theatrical release-related product vs. prior yearUS net sales were $154.5 million, down 40% compared to Q3 2024 Rest of World net sales were $56.7 million, down 15% compared to Q3 2024Gross margin of 32.0% vs. 33.8% in Q3 2024, driven by US tariffs and higher royalty expense Gross profit of $67.6 million, down $41.2 million compared...

Portage, Michigan, Oct. 30, 2025 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) reported operating results for the third quarter of 2025: Third Quarter ResultsReported net sales increased 10.3% to $6.1 billion Organic net sales increased 9.5% Reported operating income margin of 18.7% Adjusted operating income margin(1) increased 90 bps to 25.6% Reported EPS increased 2.8% to $2.22 Adjusted EPS(1) increased 11.1% to $3.19  Third Quarter Net Sales Growth Overview  Reported   Foreign Currency Exchange   Constant Currency   Acquisitions / Divestitures   OrganicMedSurg and Neurotechnology         14.4         %           0.5         %           13.9         %           5.5         %           8.4         %Orthopaedics         3.9                     0.8                     3.1                     (8.3)            11.4          Total         10.3         %           0.7         %           9.6         %           0.1         %           9.5         %“We...

Closed $50 Million Financing to Fund Gemini-II Platform Completion and Commence Plato Chip Design SUNNYVALE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) — GSI Technology, Inc. (Nasdaq: GSIT) today reported financial results for its second fiscal quarter ended September 30, 2025. Summary Comments for Second Quarter Fiscal Year 2026Revenue increased 3% sequentially and 42% year-over-year, fueled by strong market momentum for leading SRAM solutions; Quarter-end cash balance of $25.3 million, up from $13.4 million at the end of Q4 FY2025, including proceeds from the “at-the-market” (ATM) program; Subsequent to quarter-end, closed a registered direct offering for gross proceeds of $50 million; The Space Development Agency awarded an additional $752,000 under our existing SBIR to characterize our current Gemini-II die for radiation tolerance;...

Highlights: GAAP diluted earnings per share (EPS) of $0.47 for the third quarter Third quarter revenue of $934 million Non-GAAP adjusted EPS of $0.49, which excludes adjusted items in the quarter Operating income of $39 million or 4.2% of revenue, adjusted operating income (non-GAAP) of $41 million or 4.4% of revenue Closed on the acquisitions of Marten Transport Intermodal assets and SITH, LLC Strong balance sheet with net debt/EBITDA LTM (non-GAAP) of 0.4x as of September 30, 2025OAK BROOK, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) — Hub Group, Inc. (Nasdaq: HUBG) announced third quarter 2025 net income of $29 million and diluted earnings per share of $0.47. Adjusting for certain expenses of $1.2 million (pre-tax), third quarter 2025 adjusted net income (non-GAAP) of $30 million decreased 6% from the prior year adjusted net...

Raises Full-year Guidance CHARLOTTE, N.C., Oct. 30, 2025 (GLOBE NEWSWIRE) — SPX Technologies, Inc. (NYSE:SPXC) (“SPX”, the “Company”, “we” or “our”) today reported results for the third quarter ended September 27, 2025. Third Quarter Highlights (amounts presented for continuing operations; all comparisons against the third quarter of 2024, unless otherwise noted)Revenue of $592.8 million, up 22.6% GAAP income from continuing operations of $63.1 million, up 24.0% GAAP EPS of $1.29, up 19.4% Adjusted EPS* of $1.84, up 32.4% Adjusted EBITDA* of $136.1 million, up 30.9%Raising 2025 Guidance (all comparisons against the full year 2024, unless otherwise noted)Maintaining revenue range of $2.225 to $2.275 billion, up ~13% year-on-year at the midpoint. Adjusted EBITDA* range of $495 to $515 million, up ~20% year-on-year at the midpoint...

SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended September 30, 2025. Third Quarter 2025 Financial HighlightsRevenue of $192.9 million, a 30.7% increase compared to third quarter 2024 Gross margin of 71.1%, a 230-basis point increase compared to third quarter 2024 Unrestricted cash, cash equivalents, and marketable securities of $565.2 million as of September 30, 2025 Increased fiscal year 2025 guidance for revenue and adjusted EBITDA marginRecent Operational HighlightsThird quarter 2025 record quarterly revenue driven by continued momentum in core long-term continuous monitoring business, sustained demand...

Company to Host Conference Call Today, October 30, at 4:30pm ET BOCA RATON, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) — INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announces its financial results for the quarter ended September 30, 2025 and provides a business update. Q3 2025 and Recent Corporate Highlights   CORDStrom™ Platform:Announced successful completion of first two commercial pilot-scale manufacturing runs of CORDStrom™ at CGT Catapult in preparation of regulatory filings to seek approval of CORDStrom™ for recessive dystrophic epidemolysis bullosa (RDEB). CORDStrom™ is on target to file an MAA submission mid-2026, followed shortly thereafter...